PHARMACY PROVIDERS, PLEASE NOTE!!!
PLEASE
MAKE THE FOLLOWING CHANGES TO APPENDIX A:
DRUG |
DOSAGE |
STRGTH |
MAC |
EFF.DATE |
ALCLOMETASONE DIPROP |
45G TOP CRE |
0.05% |
$0.8283 |
02/18/06 |
ALCLOMETASONE DIPROP |
45G TOP OIN |
0.05% |
$0.8283 |
02/18/06 |
CEFACLOR |
CAPSULE |
250MG |
OFF MAC |
02/18/06 |
CEFACLOR |
CAPSULE |
500MG |
OFF MAC |
02/18/06 |
CEFACLOR 150 |
SUSP RECON |
125MG |
OFF MAC |
02/18/06 |
CEFACLOR 100 |
SUSP RECON |
187MG |
OFF MAC |
02/18/06 |
CEFACLOR 150 |
SUSP RECON |
250MG |
OFF MAC |
02/18/06 |
CEFACLOR 100 |
SUSP RECON |
375MG |
OFF MAC |
02/18/06 |
CHLORPROPAMIDE |
TABLET |
100MG |
$0.2325 |
02/18/06 |
CHLORPROPAMIDE |
TABLET |
250MG |
$0.4917 |
02/18/06 |
CITALOPRAM HYDROBROMIDE |
TABLET |
10MG |
$0.2963 |
02/18/06 |
CITALOPRAM HYDROBROMIDE |
TABLET |
20MG |
$0.3090 |
02/18/06 |
CITALOPRAM HYDROBROMIDE |
TABLET |
40MG |
$0.3224 |
02/18/06 |
DESIPRAMINE HCL |
TABLET |
25MG |
$0.2835 |
02/18/06 |
FLUOROMETHALONE 5ML |
OPHTH DROPS |
0.1% |
OFF MAC |
02/18/06 |
GABAPENTIN |
TABLET |
600MG |
$2.4704 |
02/18/06 |
GABAPENTIN |
TABLET |
800MG |
$2.9586 |
02/18/06 |
GLIMEPIRADE |
TABLET |
1MG |
$0.1341 |
02/18/06 |
GLIMEPIRADE |
TABLET |
2MG |
$0.2174 |
02/18/06 |
GLIMEPIRADE |
TABLET |
4MG |
$0.4100 |
02/18/06 |
GLYBURIDE |
TABLET |
1.25MG |
$0.1244 |
02/18/06 |
GLYBURIDE |
TABLET |
1.5MG |
$0.1875 |
02/18/06 |
GLYBURIDE |
TABLET |
2.5MG |
$0.1893 |
02/18/06 |
GLYBURIDE |
TABLET |
3MG |
$0.2175 |
02/18/06 |
GLYBURIDE |
TABLET |
5MG |
$0.2831 |
02/18/06 |
HALOBETASOL PROP. 50GM |
TOP CRE |
0.05% |
$1.4766 |
02/18/06 |
HYDROXYZINE PAMOATE |
CAPSULE |
25MG |
$0.1150 |
02/18/06 |
HYDROXYZINE PAMOATE |
CAPSULE |
50MG |
$0.1572 |
02/18/06 |
ISONIAZID |
TABLET |
100MG |
$0.0561 |
02/18/06 |
LEFLUNOMIDE |
TABLET |
10MG |
$2.5000 |
02/18/06 |
LEFLUNOMIDE |
TABLET |
20MG |
$2.5000 |
02/18/06 |
METFORMIN HCL |
TABLET |
750MG |
$1.1498 |
02/18/06 |
MUPIROCIN 22GM |
TOP OIN |
2% |
$1.8839 |
02/18/06 |
TOLAZAMIDE |
TABLET |
250MG |
OFF MAC |
02/18/06 |
TRETINOIN 45GM |
TOP CRE |
0.025% |
$1.5693 |
02/18/06 |
ZIDOVUDINE |
TABLET |
300MG |
$3.6503 |
02/18/06 |
IF YOU ARE UNSURE ABOUT THE COVERAGE OF A DRUG
PRODUCT, PLEASE CONTACT THE PBM HELP DESK AT 1-800-648-0790
PLEASE FILE ADJUSTMENTS FOR CLAIMS THAT MAY
HAVE BEEN INCORRECTLY PAID.
ONLY THOSE PRODUCTS OF THE MANUFACTURERS WHICH
PARTICIPATE IN THE FEDERAL
REBATE PROGRAM WILL BE COVERED BY THE MEDICAID PROGRAM. PARTICIPATION MAY BE
VERIFIED IN APPENDIX C, AVAILABLE AT WWW.LAMEDICAID.COM
ATTENTION MENTAL HEALTH REHABILITATION
PROVIDERS
EFFECTIVE 01/02/06, ALL MHR PSYCHIATRISTS WILL BE REQUIRED TO USE THE
MEDICAID ELECTRONIC CLINICAL DRUG INQUIRY (E-CDI) APPLICATION. THE E-CDI APPLICATION, WHICH IS UPDATED NIGHTLY, ALLOWS THE PSYCHIATRISTS TO
REVIEW THE RECIPIENT'S MEDICAID PAID DRUG CLAIMS FROM THE PREVIOUS FOUR MONTHS. THE MHR PROVIDER IS RESPONSIBLE FOR SUBMITTING A COPY OF THE
RECIPIENT'S CLINICAL DRUG INQUIRY PAGE WITH EACH PRIOR AUTHORIZATION REQUEST
SUBMITTED. THE MHR ENROLLED PSYCHIATRIST MUST SIGN A PRINTED COPY OF THE E-CDI SCREEN,
INDICATING A REVIEW OF THE RECIPIENT'S PRESCRIPTION UTILIZATION WAS COMPLETED. IF THE MHR PROVIDER FAILS TO SUBMIT THIS
INFORMATION WITH THE PRIOR AUTHORIZATION REQUEST, THE REQUEST WILL BE DENIED. IN ORDER TO GAIN ACCESS INTO THE MEDICAID E-CDI APPLICATION,
THE PSYCHIATRIST MUST ESTABLISH AN ONLINE ACCOUNT WITH LAMEDICAID.COM. THE FOLLOWING IS NEEDED TO
ESTABLISH AN ONLINE ACCOUNT: A VALID 7- DIGIT PROVIDER ID # ASSIGNED BY LOUISIANA MEDICAID, AN INTERNET ACCT.
WITH AN INTERNET SERVICE PROVIDER, VALID EMAIL ADDRESS, AND A WEB BROWSER THAT SUPPORTS SSL WITH 128-BIT
ENCRYPTION (EXAMPLE: MICROSOFT INTERNET EXPLORER V5 OR V6).
ATTENTION DENTAL PROVIDERS
CLAIMS FOR PAYMENT OF PRIMARY AMALGAMS (D2140, D2150, AND D2160 - TEETH
A THROUGH T) WERE INCORRECTLY REIMBURSED FOR DATES OF SERVICE JANUARY 1,2006 THROUGH JANUARY 13, 2006. A SYSTEM RECYCLE WILL OCCUR ON THE
REMITTANCE ADVICE DATED JANUARY 24, 2006 IN ORDER TO RECOVER THE OVERPAYMENT FOR THESE SERVICES. SHOULD YOU HAVE ANY QUESTIONS, YOU MAY
CONTACT THE MEDICAID DENTAL UNIT BY CALLING 225-216-6470.
OUTPATIENT VISIT LIMIT CHANGE TO CALENDAR
YEAR
EFFECTIVE IMMEDIATELY, THE NUMBER OF REMAINING 2006 OUTPATIENT VISITS
REFLECTED ON THE REVS, MEVS, AND E-MEVS SYSTEMS WILL BE BASED ON CALENDAR YEAR. (JANUARY 1 - DECEMBER 31)
PROVIDERS WILL BE NOTIFIED WHEN PROGRAMMING HAS BEEN COMPLETED TO
CORRECTLY REFLECT THE REMAINING OUTPATIENT VISITS FOR DATES OF SERVICE JULY 1 - DECEMBER 31, 2005, ON REVS, MEVS, AND
E-MEVS.
CLAIMS IMPROPERLY DENIED FOR EXCEEDING THE MAXIMUM NUMBER OF VISITS
DURING THE CHANGE FROM STATE FISCAL YEAR TO CALENDAR YEAR HAVE BEEN RECYCLED AND WILL APPEAR ON THE REMITTANCE ADVICE OF JANUARY 31, 2006.
ALL PROVIDERS
THERE WAS A CLAIMS PROCESSING ERROR ASSOCIATED WITH CERTAIN CLAIMS THAT
PREVIOUSLY PENDED AND/OR DENIED FOR ERROR CODE 495. WE HAVE RECYCLED THESE CLAIMS SO THAT THEY WILL PROCESS CORRECTLY AND THE RESULTS APPEAR
ON THIS REMITTANCE ADVICE.